Patients with rare or neglected cancers in Korea will face lower drug costs and gain greater access to treatment from Friday, ...
South Korea expands insurance to cover three cancer drugs and first combo Coverage widens from October for Retsevmo, Vyloy, ...
Hosted on MSN
Oncologists explain why they prescribe Keytruda to cancer patients, when and how it works
Keytruda is an immunotherapy drug that is prescribed to cancer patients and is used to treat different types of cancer. It was first approved by the FDA in 2014 for the treatment of advanced or ...
Oncology drug development is no longer a singles market as pharmaceutical companies increasingly rely on combination therapies to boost cancer-fighting power and overcome drug resistance. One power ...
From today, the Australian government will expand Pharmaceutical Benefit Scheme (PBS) access to the drug Keytruda for three additional types of cancer. This is part of a broader shift away from cancer ...
Interim data from a large trial showed the experimental vaccine, when combined with Merck's blockbuster immunotherapy Keytruda, helped reduce the risk of melanoma recurrence and spread in patients ...
- ATG-022 is Antengene's CLDN18.2 antibody-drug conjugate; KEYTRUDA ® (pembrolizumab) is MSD's anti-PD-1 therapy. ATG-022 is uniquely positioned in the global landscape, with data supporting ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results